GLHMs Ltd - Medical Training in Longevity & Hormones
GLHMs Ltd ("GLHMs"), is a medical training platform in all areas related to longevity, menopause and andropause. In July 2023, the PEAL Fund took a majority stake in the company.
GLHMs provides a structured pathway for medical professionals to progress from the typical medical school mindset of treating patients after they have become unwell, to considering how they can improve their patients’ healthspan and prevent illness.
Innovative training techniques are at the core of GLHMs. They teach medical professionals how to become experts through courses, conferences and partnering with Key Opinion Leaders in the longevity space in order to ensure that the GLHMs training keeps up to date with what is a rapidly evolving medical field.
Training covers areas such as menopause, andropause, weight management, brain function, immunity and peptides, thereby providing a complete program for medical practitioners to implement longevity based treatments into their clinics.
PEAL’s experience from its first deal in Derma Medical has taught them the power of medical training. By educating doctors with the newest and most effective techniques in a specific medical area, you can change the lives of hundreds of thousands of patients for the better.
Mission
Mission
GLHMs' mission is to raise the awareness of longevity related
treatments for medical professionals, who can, in turn help the wider population to live healthier for longer.
Benefiting Both the Patient and the Doctor
Benefiting Both the Patient and the Doctor
Not only do the GLHMs courses allow doctors to provide their patients with the latest and best techniques and treatments to treat longevity related issues, they have also opened up new revenue streams for the doctors. These (recurring) revenue streams include initial consultations, blood testing and supplements.